Eyam Vaccines and Immunotherapeutics: Eyam Announces Partnership with Mitacs to Fund Next Generation COVID-19 Vaccine Technologies

VANCOUVER, BC / ACCESSWIRE / October 11, 2022 / Eyam Vaccines and Immunotherapeutics ltd. ("Eyam" or the "Company"), today announced a partnership with Mitacs to fund Post-Doctoral Fellowships at the University

Related Keywords

Eyam ,Derbyshire ,United Kingdom ,Canada ,Vancouver ,British Columbia ,British ,Kostenloser Wertpapierhandel ,Ryan Thomas ,Wilfred Jefferies ,University Of British Columbia ,Eyam Vaccines ,Post Doctoral Fellowships ,Professor Wilfred Jefferies ,Michael Smith Laboratories ,Vaccines ,Immunotherapeutics ,Nnounces ,Partnership ,Mitacs ,Fund ,Text ,Generation ,Covid ,Vaccine ,Technologies ,